Does low serum zinc impair thyroid hormone signaling and increase thyroid autoantibody activity?

Zinc is an essential trace element required for maintaining thyroid hormone homeostasis and immune system balance.

Thyroid hormone metabolism and genomic signaling

• Receptor function: Nuclear thyroid hormone receptors (TRα, TRβ) are zinc-finger transcription factors. Zinc coordination is structurally mandatory for proper receptor folding, DNA binding to thyroid-response elements, and high-affinity T3-receptor interaction. Low zinc levels compromise this mechanism, creating post-receptor signaling resistance.
• Hormone conversion: Zinc is a vital cofactor and structural component for type I and type II iodothyronine deiodinases, the metalloenzymes that convert thyroxine (T4) into active free T3. Zinc deficiency impairs peripheral deiodinase activity, leading to lower free T3.
• Biosynthesis: Zinc acts as a critical cofactor for thyroid-specific transcription factors TTF-1 and TTF-2, which are required for transcribing key thyroid-synthetic genes, including thyroperoxidase and thyroglobulin.

Immune regulation and autoantibody activity

• T-cell homeostasis: Zinc status regulates the critical balance between regulatory T (Treg) cells and pro-inflammatory Th17 cells. Low serum zinc levels (<70 µg/dL) impair Treg suppressor phenotypes and favor Th17 pathway activation, compromising immune tolerance.
• Autoimmunity: This Treg/Th17 imbalance is associated with a loss of tolerance to thyroid antigens, manifesting as elevated thyroid peroxidase (TPOAb) and thyroglobulin (TgAb) autoantibody titers. While observational studies show a clear inverse correlation between serum zinc and these antibodies, clinical trials indicate that zinc supplementation alone does not consistently lower antibody titers.

Bottom line

• Low serum zinc impairs thyroid hormone receptor function, thyroid-specific transcription factors (TTF-1/TTF-2), deiodinase-mediated T4-to-T3 conversion, and Treg-mediated immune tolerance. Correcting a zinc deficiency can successfully normalize free T3 levels, though it may not reliably lower active thyroid autoantibody titers.